As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.
19 Analysts have issued a Cochlear forecast:
19 Analysts have issued a Cochlear forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 2,343 2,343 |
5%
5%
|
|
| Gross Profit | 1,738 1,738 |
2%
2%
|
|
| EBITDA | - - |
-
|
|
| EBIT (Operating Income) EBIT | 533 533 |
0%
0%
|
|
| Net Profit | 389 389 |
9%
9%
|
|
In millions AUD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
| Head office | Australia |
| CEO | Diggory Howitt |
| Employees | 5,047 |
| Founded | 1983 |
| Website | www.cochlear.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


